Name: Buy Retatrutide 10mg | Premium Peptides for Sale
SKU: PEP-RETA-10MG
Price: 135.00 USD
Availability: InStock

Research Use

Product Name	Product Description
BPC-157	BPC-157 is a synthetic peptide fragment derived from a protein found in human gastric juice, known as body protection compound. It has attracted considerable interest in the scientific community for its potential role in supporting cellular repair, angiogenesis, and tissue regeneration. This compound is actively being studied in various experimental models to further understand its impact on gastrointestinal healing, musculoskeletal recovery, and inflammatory response pathways. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “BPC-157” is a commonly used research designation for this peptide and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. BPC-157 is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
DSIP-Delta-Sleep	DSIP (Delta Sleep-Inducing Peptide) is a synthetic peptide originally isolated from the hypothalamus and extensively studied for its potential role in sleep regulation, stress response modulation, and endocrine system balance. Scientific investigations have explored its presence in neuroendocrine pathways and its possible influence on circadian rhythm stabilization, hormonal secretion, and neuroprotective functions. Ongoing studies in experimental models aim to better understand DSIP’s biological significance and mechanisms of action. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “DSIP” is a commonly used research designation for this peptide and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. DSIP is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
CJC-1295-ND	CJC-1295 No-DAC (mod GRF 1-29) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), engineered to stimulate the release of endogenous growth hormone through selective GHRH receptor activation. Unlike the DAC version, this No-DAC formulation is shorter-acting, making it a valuable tool in studies examining pulsatile hormone secretion, pituitary function, and growth factor signaling. It is frequently used in experimental models to investigate endocrine regulation, muscle growth, and cellular repair mechanisms. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “CJC-1295” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. CJC-1295 is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
Epithalon	Epithalon (also known as Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled after the natural pineal gland extract, epithalamin. It has been extensively studied for its potential role in modulating telomerase activity, promoting telomere elongation, and influencing cellular aging processes. Research indicates that Epitalon may impact various physiological functions, including antioxidant defense mechanisms, neuroendocrine regulation, and circadian rhythm maintenance. Experimental models have explored its effects on lifespan extension, chromosomal stability, and the modulation of gene expression related to aging and cellular differentiation. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “Epithalon” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Epitalon is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
GHK-Cu	GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding peptide widely studied for its regenerative and reparative properties in scientific research. It plays a significant role in wound healing, tissue remodeling, and skin regeneration. GHK-Cu has also been explored for its involvement in anti-inflammatory activity, antioxidant defense, and the regulation of gene expression related to tissue repair and collagen synthesis. Experimental models continue to investigate its applications in dermatology, neurology, and anti-aging research. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “GHK-Cu” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. GHK-Cu is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
Ipamorelin	Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue (GHS), known for its strong affinity for the ghrelin receptor (GHS-R1a). It has been extensively studied for its ability to stimulate the natural release of growth hormone without significantly affecting cortisol or prolactin levels. Research involving Ipamorelin often focuses on its potential roles in muscle growth, recovery, body composition, and the regulation of the somatotropic axis. Its targeted action and favorable safety profile make it a valuable compound in experimental endocrinology and regenerative medicine studies. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “Ipamorelin” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Ipamorelin is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
MT2	Melanotan 2 (MT2) is a synthetic peptide analog of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring peptide involved in pigmentation and energy homeostasis. MT2 has been widely studied in scientific research for its role in stimulating melanogenesis, enhancing photoprotection, and exploring mechanisms related to sexual function and appetite modulation. Ongoing investigations using experimental models aim to further understand its interactions with melanocortin receptors and related physiological pathways. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “Melanotan 2” (MT2) is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Melanotan 2 is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
Mots-c	MOTS-c is a mitochondrial-derived peptide (MDP) encoded by the 12S rRNA region of mitochondrial DNA. It has gained substantial attention in scientific research for its role in regulating metabolic homeostasis, cellular stress responses, and insulin sensitivity. MOTS-c is actively studied in experimental models for its potential effects on energy expenditure, glucose utilization, and mitochondrial function. Research also suggests possible implications in aging, obesity, and exercise performance through pathways involving AMPK activation and nuclear gene expression modulation. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “MOTS-c” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. MOTS-c is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
Thymosin-A1	Thymosin Alpha-1 (Tα1) is a synthetic version of a naturally occurring thymic peptide fragment known for its immunomodulatory properties. It has been extensively studied for its role in enhancing immune function, promoting T-cell differentiation, and regulating inflammatory responses. Scientific research has explored its effects in various experimental models related to immune system dysfunction, infectious diseases, and oncology. Thymosin Alpha-1 is of particular interest in studies investigating innate and adaptive immune regulation, cytokine modulation, and host defense mechanisms. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “Thymosin Alpha-1” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Thymosin Alpha-1 is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
TB500	TB-500 is a synthetic peptide fragment derived from thymosin beta-4, a naturally occurring peptide involved in tissue repair and regeneration. It has been extensively studied in scientific research for its role in promoting cell migration, angiogenesis, and wound healing processes. TB-500 is commonly used in experimental models to investigate mechanisms of tissue remodeling, inflammation reduction, and recovery from injury. Its influence on cytoskeletal dynamics and cellular motility makes it a valuable compound in regenerative medicine research. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “TB-500” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. TB-500 is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
Retatrutide	Retatrutide is a synthetic peptide that functions as a triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. It has garnered significant interest in the scientific community for its role in research investigating metabolic regulation, energy expenditure, and hormone signaling pathways. This compound is currently being studied in various experimental models to enhance understanding of physiological mechanisms related to appetite regulation, glucose homeostasis, and weight management. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “Retatrutide” is the USAN-designated nonproprietary name for the compound and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Retatrutide is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
Tesamorelin	Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) designed to stimulate the release of endogenous growth hormone. It has been extensively studied in scientific research for its potential effects on reducing visceral adipose tissue, improving lipid metabolism, and influencing body composition. Tesamorelin is used in experimental models to investigate endocrine regulation, metabolic disorders, and the therapeutic potential of growth hormone modulation. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “Tesamorelin” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Tesamorelin is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
Semaglutide	Semaglutide is a synthetic peptide that functions as a glucagon-like peptide-1 (GLP-1) receptor agonist. It has garnered significant interest within the scientific community for its role in research focused on metabolic function, appetite regulation, and glucose homeostasis. This compound is being studied in various preclinical and in vitro models to investigate mechanisms related to insulin signaling, energy balance, and endocrine system pathways. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. *Disclaimer: “Semaglutide” is the USAN-designated nonproprietary name for the compound and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Semaglutide is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
Tirzepatide	Tirzepatide is a synthetic peptide that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has attracted significant attention in the scientific community for its role in research exploring metabolic regulation, energy balance, and hormone signaling pathways. This compound is being studied in various experimental models to better understand the physiological mechanisms related to appetite control, glucose metabolism, and endocrine function. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. *Disclaimer: “Tirzepatide” is the USAN-designated nonproprietary name for the compound and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Tirzepatide is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
Semax	Semax is a synthetic peptide analog of the adrenocorticotropic hormone (ACTH) fragment, known for its neuroprotective and nootropic properties. It has been widely studied in scientific research for its effects on cognitive function, memory enhancement, and neuroregeneration. Semax is utilized in experimental models to explore mechanisms of neuroprotection, stress response modulation, and neurotransmitter regulation. Its potential roles in improving cerebral blood flow and reducing neuroinflammation make it a compound of interest in neuroscience research. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “Semax” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Semax is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
PT-141	PT-141 (Bremelanotide) is a synthetic peptide and melanocortin receptor agonist, primarily studied for its potential effects on sexual dysfunction and arousal. It acts by targeting melanocortin receptors in the central nervous system, influencing pathways involved in sexual motivation and behavior. PT-141 is widely used in experimental models to investigate neuroendocrine regulation, reproductive biology, and the modulation of sexual response. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “PT-141” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. PT-141 is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
Selank	Selank is a synthetic heptapeptide analog of the endogenous tetrapeptide tuftsin, recognized for its anxiolytic, neuroprotective, and cognitive-enhancing properties. It has been extensively studied in scientific research for its potential effects on anxiety reduction, modulation of neurotransmitter systems, and immune system regulation. Selank is used in experimental models to investigate mechanisms related to stress response, memory improvement, and neuroinflammation. Its multifaceted activity makes it a valuable compound in neuroscience and psychopharmacology research. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “Selank” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Selank is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
SNAP-8	SNAP-8 is a synthetic peptide fragment derived from the N-terminal end of the SNAP-25 protein, designed to modulate neurotransmitter release by interfering with SNARE complex formation. It has been extensively studied for its potential to reduce muscle contraction and mimic the effects of botulinum toxin, making it of interest in cosmetic and neuromuscular research. SNAP-8 is used in experimental models investigating mechanisms of muscle relaxation, wrinkle reduction, and neurochemical signaling. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “SNAP-8” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. SNAP-8 is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
DSIP	DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide studied for its potential role in sleep regulation and modulation of the central nervous system. Research explores its effects on sleep induction, stress response, and neuroendocrine function. DSIP is used in experimental models to investigate mechanisms related to sleep architecture, hormonal balance, and neurophysiological processes. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “DSIP” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. DSIP is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
BAC-WATER	Bacteriostatic Water (Bac Water) is sterile, purified water containing 0.9% benzyl alcohol as a preservative to inhibit bacterial growth. It is widely used in laboratory research for reconstituting lyophilized peptides and proteins prior to in vitro experiments. Its bacteriostatic properties help maintain sterility during multiple-dose use in research settings. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “DSIP” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. DSIP is strictly intended for in vitro laboratory research use and is not approved for human or animal use.
NAD+	NAD+ (Nicotinamide Adenine Dinucleotide) is a critical coenzyme found in all living cells, playing a fundamental role in redox reactions, mitochondrial energy production, and cellular metabolism. It serves as an essential electron transporter in metabolic pathways such as glycolysis, the citric acid cycle, and oxidative phosphorylation. NAD+ has garnered significant attention in scientific research for its role in aging, cellular repair, and maintenance of genomic stability. Current research explores its potential in supporting mitochondrial function, activating sirtuins, and regulating oxidative stress responses. It is also being studied in experimental models related to neurodegeneration, metabolic disorders, and overall cellular resilience. For additional information, including access to peer-reviewed literature and supporting scientific data, please visit our Reference Library. Disclaimer: “NAD+” is a research chemical designation and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. NAD+ is strictly intended for in vitro laboratory research use and is not approved for human or animal use.

Product Specifications

Please read our Terms and Conditions before purchasing any product from this website.

Row No	Chemical Name	Attribute Name	Attribute Description
1	Semaglutide	CAS #	910463-68-2
1	DSIP-Sleep-Inducing	CAS #	62568-57-4
1	PT-141	CAS #	1607799-13-2
1	SNAP-8	Synonyms	SCHEMBL20154760 BCP12742 SNAP-8(Acetyl Glutamyl Heptapeptide-3) Acetyl GlutaMyl Heptapeptide-3;Acetyl GlutaMyl Octapeptide-3;Acetyl Octapeptide-3;Acetyl Octapetpide-3;Acetyl Octapeptide-8;Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH
1	Retatrutide	CAS #	2381089-83-2
2	Semaglutide	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
2	PT-141	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
2	SNAP-8	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
2	DSIP-Sleep-Inducing	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
2	Retatrutide	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	Semaglutide	Product Color	White lyophilized powder
3	PT-141	Product Color	White lyophilized powder
3	SNAP-8	Product Color	White lyophilized powder
3	DSIP-Sleep-Inducing	Product Color	White lyophilized powder
3	Retatrutide	Product Color	White lyophilized powder
3	Tesamorelin	Product Color	White lyophilized powder
4	Semaglutide	PubChem CID	56843331
4	DSIP-Sleep-Inducing	PubChem CID	68816
4	PT-141	PubChem CID	9941379
4	SNAP-8	PubChem CID	86080331
4	Retatrutide	PubChem CID	474492335
4	Tesamorelin	PubChem CID	146681838
5	Semaglutide	Molecular Weight	4113.64 g/mol
5	PT-141	Molecular Weight	1025.2 g/mol
5	DSIP-Sleep-Inducing	Molecular Weight	848.8 g/mol
5	SNAP-8	Molecular Weight	1075.2 g/mol
5	Retatrutide	Molecular Weight	4731.34 g/mol
5	Tesamorelin	Molecular Weight	5136 g/mol
6	Semaglutide	Molecular Formula	C187H291N45059
6	PT-141	Molecular Formula	C50H68N14O10
6	Retatrutide	Molecular Formula	C221H342N46O68
6	Tesamorelin	Molecular Formula	C221H366N72O67S
7	Semaglutide	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
7	PT-141	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
7	Retatrutide	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
7	SNAP-8	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
9	Tesamorelin	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/146681838
9	Semaglutide	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/5684333
9	SNAP-8	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/SNAP-8_Acetyl-Glutamyl-Heptapeptide-3
9	PT-141	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/Bremelanotide
9	Retatrutide	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/substance/474492335
1	GHK-Cu-Raw	CAS #	49557-75-7
1	Tesamorelin	CAS #	218949-48-5
2	GHK-Cu-Raw	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
2	Tesamorelin	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	GHK-Cu-Raw	Product Color	White powder
4	GHK-Cu-Raw	PubChem CID	73587
5	GHK-Cu-Raw	Molecular Weight	340.38 g/mol
6	GHK-Cu-Raw	Molecular Formula	C14H24N6O4
7	GHK-Cu-Raw	Storage	Store in a cool dark place. For best preservation, store at 4°C or colder.
9	GHK-Cu-Raw	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/73587
1	Semaglutide-Raw	CAS #	910463-68-2
2	Semaglutide-Raw	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	Semaglutide-Raw	Product Color	White powder
4	Semaglutide-Raw	PubChem CID	56843331
5	Semaglutide-Raw	Molecular Weight	4113.64 g/mol
6	Semaglutide-Raw	Molecular Formula	C187H291N45059
7	Semaglutide-Raw	Storage	Store in a cool dark place. For best preservation, store at 4°C or colder.
9	Semaglutide-Raw	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/5684333
1	BPC-157-Raw	CAS #	137525-51-0
2	BPC-157-Raw	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	BPC-157-Raw	Product Color	White powder
4	BPC-157-Raw	PubChem CID	9941957
5	BPC-157-Raw	Molecular Weight	1419.5 g/mol
6	BPC-157-Raw	Molecular Formula	C62H98N16O22
7	BPC-157-Raw	Storage	Store in a cool dark place. For best preservation, store at 4°C or colder.
9	BPC-157-Raw	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/9941957
1	Tirzepatide-Raw	CAS #	2023788-19-2
2	Tirzepatide-Raw	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	Tirzepatide-Raw	Product Color	White powder
4	Tirzepatide-Raw	PubChem CID	Not available because this is not a discrete structure.
5	Tirzepatide-Raw	Molecular Weight	Not available
6	Tirzepatide-Raw	Molecular Formula	C187H291N45059
7	Tirzepatide-Raw	Storage (Shelf Life)	Store in a cool dark place. For best preservation, store at 4°C or colder.
9	Tirzepatide-Raw	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/Tirzepatide
1	BPC-157	CAS #	137525-51-0
2	BPC-157	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	BPC-157	Product Color	White lyophilized powder
4	BPC-157	PubChem CID	9941957
5	BPC-157	Molecular Weight	1419.5 g/mol
6	BPC-157	Molecular Formula	C62H98N16O22
7	BPC-157	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
9	BPC-157	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/9941957
1	CJC-1295-ND	CAS #	863288-34-0
2	CJC-1295-ND	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	CJC-1295-ND	Product Color	White lyophilized powder
4	CJC-1295-ND	PubChem CID	56841945
5	CJC-1295-ND	Molecular Weight	3367.9 g/mol
6	CJC-1295-ND	Molecular Formula	C152H252N44O42
7	CJC-1295-ND	Storage	Store in a cool, dark place. For best preservation, store them under refrigeration at 4°C or colder.
9	CJC-1295-ND	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/56841945
1	Epithalon	CAS #	307297-39-8
2	Epithalon	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	Epithalon	Product Color	White lyophilized powder
4	Epithalon	PubChem CID	219042
5	Epithalon	Molecular Weight	390.35 g/mol
6	Epithalon	Molecular Formula	C14H22N4O9
6	DSIP-Sleep-Inducing	Molecular Formula	C35H48N10O15
7	Epithalon	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
7	DSIP-Sleep-Inducing	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
9	Epithalon	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/219042
1	GHK-Cu	CAS #	49557-75-7
2	GHK-Cu	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	GHK-Cu	Product Color	Blue powder
4	GHK-Cu	PubChem CID	73587
5	GHK-Cu	Molecular Weight	340.38 g/mol
6	GHK-Cu	Molecular Formula	C14H24N6O4
7	GHK-Cu	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
9	GHK-Cu	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/73587
1	Ipamorelin	CAS #	170851-70-4
2	Ipamorelin	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	Ipamorelin	Product Color	White lyophilized powder
4	Ipamorelin	PubChem CID	9831659
5	Ipamorelin	Molecular Weight	711.9 g/mol
6	Ipamorelin	Molecular Formula	C38H49N9O5
7	Ipamorelin	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
9	Ipamorelin	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/9831659
9	DSIP-Sleep-Inducing	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/68816
1	Mots-C	CAS #	1627580-64-6
2	Mots-C	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	Mots-C	Product Color	White lyophilized powder
4	Mots-C	PubChem CID	146675088
5	Mots-C	Molecular Weight	2174.6 g/mol
6	Mots-C	Molecular Formula	C101H152N28O22S2
7	Mots-C	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
9	Mots-C	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/146675088
1	Melanotan-MT2	CAS #	121062-08-6
2	Melanotan-MT2	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	Melanotan-MT2	Product Color	White lyophilized powder
4	Melanotan-MT2	PubChem CID	92432
5	Melanotan-MT2	Molecular Weight	1024.2 g/mol
6	Melanotan-MT2	Molecular Formula	C50H69N15O9
7	Melanotan-MT2	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
9	Melanotan-MT2	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/92432
1	TB-500	CAS #	77591-33-4
2	TB-500	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	TB-500	Product Color	White lyophilized powder
4	TB-500	PubChem CID	16132341
5	TB-500	Molecular Weight	4963 g/mol
6	TB-500	Molecular Formula	C212H350N56O78S
7	TB-500	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
9	TB-500	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/16132341
1	Thymosin A1	CAS #	62304-98-7
2	Thymosin A1	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	Thymosin A1	Product Color	White lyophilized powder
4	Thymosin A1	PubChem CID	16130571
5	Thymosin A1	Molecular Weight	3108.3 g/mol
6	Thymosin A1	Molecular Formula	C129H215N33O55
7	Thymosin A1	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
9	Thymosin A1	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/Thymalfasin
1	Tirzepatide	CAS #	2023788-19-2
2	Tirzepatide	Vial Specs	Clear glass medicine vial. May differ slightly from product image.
3	Tirzepatide	Product Color	White lyophilized powder
4	Tirzepatide	PubChem CID	Not available because this is not a discrete structure.
5	Tirzepatide	Molecular Weight	Not available
6	Tirzepatide	Molecular Formula	C187H291N45059
7	Tirzepatide	Storage (Shelf Life)	For up to 2 years at 39 degrees fahrenheit and 3 years at -4 degree fahrenheit
9	Tirzepatide	Chemical Reference	https://pubchem.ncbi.nlm.nih.gov/compound/Tirzepatide

PEP-RETA-10MG-COA_000805

Reference Articles

All information provided on this site, including content in the Reference Library, is for educational and informational purposes only. Citations are presented for context and should NOT be interpreted as endorsements, claims, or representations regarding any products offered on this website. These products are not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product.

Name	Source	Subject	Reference Title	Citation	More Info
Thymosin Alpha-1	National Library of Medicine (NIH)	Cancer	A Reappraisal of Thymosin Alpha1 in Cancer Therapy	Costantini C, Bellet MM, Pariano M, Renga G, Stincardini C, Goldstein AL, Garaci E, Romani L. A Reappraisal of Thymosin Alpha1 in Cancer Therapy. Front Oncol. 2019 Sep 6;9:873. doi: 10.3389/fonc.2019.00873. PMID: 31555601; PMCID: PMC6742685.	View
Thymosin Alpha-1	National Library of Medicine (NIH)	Hepatitis B	Thymosin alpha-1 treatment in chronic hepatitis B	Wu X, Jia J, You H. Thymosin alpha-1 treatment in chronic hepatitis B. Expert Opin Biol Ther. 2015;15 Suppl 1:S129-32. doi: 10.1517/14712598.2015.1007948. Epub 2015 Feb 1. PMID: 25640173.	View
Thymosin Alpha-1	National Library of Medicine (NIH)	Cystic Fibrosis	Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis	Bellet MM, Borghi M, Pariano M, Renga G, Stincardini C, D’Onofrio F, Brancorsini S, Garaci E, Costantini C, Romani L. Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis. Eur J Med Chem. 2021 Jan 1;209:112921. doi: 10.1016/j.ejmech.2020.112921. Epub 2020 Oct 9. PMID: 33071052.	View
Thymosin Alpha-1	National Library of Medicine (NIH)	Infectious Disease	Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application	Tao N, Xu X, Ying Y, Hu S, Sun Q, Lv G, Gao J. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application. Molecules. 2023 Apr 17;28(8):3539. doi: 10.3390/molecules28083539. PMID: 37110771; PMCID: PMC10144173.	View
Thymosin Alpha-1	National Library of Medicine (NIH)	Respiratory (COPD)	Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients	Jia Z, Feng Z, Tian R, Wang Q, Wang L. Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients. Immunopharmacol Immunotoxicol. 2015;37(4):388-92. doi: 10.3109/08923973.2015.1069837. PMID: 26250523.	View
Thymosin Alpha-1	ACS Omega	Cancer (Lung)	Modified Thymosin Alpha 1 Distributes and Inhibits the Growth of Lung Cancer in Vivo	Renhao Peng, Caoying Xu, Heng Zheng, and Xingzhen Lao ACS Omega 2020 5 (18), 10374-10381 DOI: 10.1021/acsomega.0c00220	View
Semaglutide	National Library of Medicine (NIH)	Diabetes	Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes	Mahapatra MK, Karuppasamy M, Sahoo BM. Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes. Rev Endocr Metab Disord. 2022 Jun;23(3):521-539. doi: 10.1007/s11154-021-09699-1. Epub 2022 Jan 7. PMID: 34993760; PMCID: PMC8736331.	View
Retatrutide	National Library of Medicine (NIH)	Diabetes	Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA	Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. Lancet. 2023 Aug 12;402(10401):529-544. doi: 10.1016/S0140-6736(23)01053-X. Epub 2023 Jun 26. PMID: 37385280.	View
Semaglutide	National Library of Medicine (NIH)	Weight Loss	Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity	Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, Hurtado MD, Acosta A. Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Netw Open. 2022 Sep 1;5(9):e2231982. doi: 10.1001/jamanetworkopen.2022.31982. PMID: 36121652; PMCID: PMC9486455.	View
Retatrutide	National Library of Medicine (NIH)	Weight Loss	Unleashing the power of retatrutide: A possible triumph over obesity and overweight: A correspondence	Naeem M, Imran L, Banatwala UESS. Unleashing the power of retatrutide: A possible triumph over obesity and overweight: A correspondence. Health Sci Rep. 2024 Feb 5;7(2):e1864. doi: 10.1002/hsr2.1864. PMID: 38323122; PMCID: PMC10844714.	View
Retatrutide	National Library of Medicine (NIH)	Addiction	The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders	Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A. The role of glucagon-like peptide 1 (GLP-1) in addictive disorders. Br J Pharmacol. 2022 Feb;179(4):625-641. doi: 10.1111/bph.15677. PMID: 34532853; PMCID: PMC8820218.	View
Semaglutide	National Library of Medicine (NIH)	Liver (NAFLD)	Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity	Newsome P, Francque S, Harrison S, Ratziu V, Van Gaal L, Calanna S, Hansen M, Linder M, Sanyal A. Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity. Aliment Pharmacol Ther. 2019 Jul;50(2):193-203. doi: 10.1111/apt.15316. Epub 2019 Jun 10. PMID: 31246368; PMCID: PMC6617813.	View
BPC-157	National Library of Medicine (NIH)	Healing (Tendon)	The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration	Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011 Mar;110(3):774-80. doi: 10.1152/japplphysiol.00945.2010. Epub 2010 Oct 28. PMID: 21030672.	View
BPC-157	National Library of Medicine (NIH)	Arthritis (Knee Pain)	Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain	Lee E, Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Altern Ther Health Med. 2021 Jul;27(4):8-13. PMID: 34324435.	View
BPC-157	National Library of Medicine (NIH)	Wound Healing	Stable Gastric Pentadecapeptide BPC 157 and Wound Healing	Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Pavlov KH, Petrovic A, Sikiric S, Vranes H, Prtoric A, Zizek H, Durasin T, Dobric I, Staresinic M, Strbe S, Knezevic M, Sola M, Kokot A, Sever M, Lovric E, Skrtic A, Blagaic AB, Sikiric P. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2021 Jun 29;12:627533. doi: 10.3389/fphar.2021.627533. PMID: 34267654; PMCID: PMC8275860.	View
GHK-Cu	National Library of Medicine (NIH)	Multiple (Anti-aging, Healing, Inflammation, Hair Growth)	Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data	Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018 Jul 7;19(7):1987. doi: 10.3390/ijms19071987. PMID: 29986520; PMCID: PMC6073405.	View
GHK-Cu	National Library of Medicine (NIH)	Hair Regeneration	Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application	Liu T, Liu Y, Zhao X, Zhang L, Wang W, Bai D, Liao Y, Wang Z, Wang M, Zhang J. Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application. Bioact Mater. 2023 Nov 1;32:502-513. doi: 10.1016/j.bioactmat.2023.10.002. PMID: 38026438; PMCID: PMC10643103.	View
CJC-1295-ND	National Library of Medicine (NIH)	Bone Density (Osteoporosis)	Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial	Landin-Wilhelmsen K, Nilsson A, Bosaeus I, Bengtsson BA. Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial. J Bone Miner Res. 2003 Mar;18(3):393-405. doi: 10.1359/jbmr.2003.18.3.393. PMID: 12619921.	View
TB-500	National Library of Medicine (NIH)	Wound Healing	Thymosin beta4 accelerates wound healing	Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999 Sep;113(3):364-8. doi: 10.1046/j.1523-1747.1999.00708.x. PMID: 10469335.	View
TB-500	National Library of Medicine (NIH)	Hair Growth	Thymosin beta 4 induces hair growth via stem cell migration and differentiation	Philp D, St-Surin S, Cha HJ, Moon HS, Kleinman HK, Elkin M. Thymosin beta 4 induces hair growth via stem cell migration and differentiation. Ann N Y Acad Sci. 2007 Sep;1112:95-103. doi: 10.1196/annals.1415.009. PMID: 17947589.	View
TB-500	National Library of Medicine (NIH)	Anti-Inflammatory	Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids	Young JD, Lawrence AJ, MacLean AG, Leung BP, McInnes IB, Canas B, Pappin DJ, Stevenson RD. Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med. 1999 Dec;5(12):1424-7. doi: 10.1038/71002. PMID: 10581087.	View
Tesamorelin	National Library of Medicine (NIH)	Visceral Fat, HIV	Visceral Fat Reduction with Tesamorelin Is Associated with Improved Liver Enzymes in HIV	Fourman LT, Czerwonka N, Feldpausch MN, Weiss J, Mamputu JC, Falutz J, Morin J, Marsolais C, Stanley TL, Grinspoon SK. Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV. AIDS. 2017 Oct 23;31(16):2253-2259. doi: 10.1097/QAD.0000000000001614. PMID: 28832410; PMCID: PMC5633509.	View
Tesamorelin	National Library of Medicine (NIH)	NAFLD	Effects of Tesamorelin on Nonalcoholic Fatty Liver Disease in HIV: A Randomized, Double-Blind, Multicenter Trial	Stanley TL, Fourman LT, Feldpausch MN, Purdy J, Zheng I, Pan CS, Aepfelbacher J, Buckless C, Tsao A, Kellogg A, Branch K, Lee H, Liu CY, Corey KE, Chung RT, Torriani M, Kleiner DE, Hadigan CM, Grinspoon SK. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV. 2019 Dec;6(12):e821-e830. doi: 10.1016/S2352-3018(19)30338-8. Epub 2019 Oct 11. PMID: 31611038; PMCID: PMC6981288.	View
Tesamorelin	National Library of Medicine (NIH)	Scarpenia, HIV	The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV	Adrian S, Scherzinger A, Sanyal A, Lake JE, Falutz J, Dubé MP, Stanley T, Grinspoon S, Mamputu JC, Marsolais C, Brown TT, Erlandson KM. The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV. J Frailty Aging. 2019;8(3):154-159. doi: 10.14283/jfa.2018.45. PMID: 31237318; PMCID: PMC6766405.	View
TB-500	National Library of Medicine (NIH)	Regenerative (Healing)	The regenerative peptide thymosin ?4 accelerates the rate of dermal healing in preclinical animal models and in patients	Treadwell T, Kleinman HK, Crockford D, Hardy MA, Guarnera GT, Goldstein AL. The regenerative peptide thymosin ?4 accelerates the rate of dermal healing in preclinical animal models and in patients. Ann N Y Acad Sci. 2012 Oct;1270:37-44. doi: 10.1111/j.1749-6632.2012.06717.x. PMID: 23050815.	View
TB-500	National Library of Medicine (NIH)	Performance Enhancement	The potential use and abuse of thymosin ?-4 in sport and exercise science	Davison G, Brown S. The potential use and abuse of thymosin ?-4 in sport and exercise science. J Sports Sci. 2013;31(9):917-8. doi: 10.1080/02640414.2013.771958. Epub 2013 Feb 20. PMID: 23421910.	View
TB-500	National Library of Medicine (NIH)	Traumatic Brain Injury	Neuroprotective and neurorestorative effects of Thymosin beta 4 treatment following experimental traumatic brain injury	Xiong Y, Mahmood A, Meng Y, Zhang Y, Zhang ZG, Morris DC, Chopp M. Neuroprotective and neurorestorative effects of thymosin ?4 treatment following experimental traumatic brain injury. Ann N Y Acad Sci. 2012 Oct;1270:51-8. doi: 10.1111/j.1749-6632.2012.06683.x. PMID: 23050817; PMCID: PMC3547647.	View
TB-500	National Library of Medicine (NIH)	Regenerative (Cardiac)	Thymosin beta4 and cardiac repair	Shrivastava S, Srivastava D, Olson EN, DiMaio JM, Bock-Marquette I. Thymosin beta4 and cardiac repair. Ann N Y Acad Sci. 2010 Apr;1194:87-96. doi: 10.1111/j.1749-6632.2010.05468.x. PMID: 20536454.	View
TB-500	National Library of Medicine (NIH)	Liver (NAFLD)	Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease	Jiang Y, Han T, Zhang ZG, Li M, Qi FX, Zhang Y, Ji YL. Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. Chronic Dis Transl Med. 2017 Jul 8;3(3):165-168. doi: 10.1016/j.cdtm.2017.06.003. PMID: 29063072; PMCID: PMC5643779.	View
Epithalon	National Library of Medicine (NIH)	Anti-Aging	Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice	Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Alimova IN, Rosenfeld SV, Zavarzina NY, Semenchenko AV, Yashin AI. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202. doi: 10.1023/a:1025114230714. PMID: 14501183.	View
Epithalon	National Library of Medicine (NIH)	Cancer (Tumors)	Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice	Kossoy G, Anisimov VN, Ben-Hur H, Kossoy N, Zusman I. Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice. In Vivo. 2006 Mar-Apr;20(2):253-7. PMID: 16634527.	View
Epithalon	Alzheimers Drug Discovery Foundation	Cognitive, Aging, Cancer	Epithalamin/Epithalon	Alzheimer’s Drug Discovery Foundation. (n.d.). Cognitive vitality reports. https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Epithalamin-and-Epithalon-Cognitive-Vitality-For-Researchers.pdf	View
Epithalon	National Library of Medicine (NIH)	Neuroendocrine Regulation (Melatonin Synthesis – Improved Sleep)	Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys	Khavinson V, Goncharova N, Lapin B. Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys. Neuro Endocrinol Lett. 2001 Aug;22(4):251-4. PMID: 11524632.	View
Ipamorelin	National Library of Medicine (NIH)	Growth Hormone	Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats	Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Horm IGF Res. 1999 Apr;9(2):106-13. doi: 10.1054/ghir.1999.9998. PMID: 10373343.	View
Ipamorelin	National Library of Medicine (NIH)	Body Composition (Hypogonadal)	Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males	Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020 Mar;9(Suppl 2):S149-S159. doi: 10.21037/tau.2019.11.30. PMID: 32257855; PMCID: PMC7108996.	View
Ipamorelin	National Library of Medicine (NIH)	Gastric Emptying (Dysmotility)	Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus	Greenwood-Van Meerveld B, Tyler K, Mohammadi E, Pietra C. Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus. J Exp Pharmacol. 2012 Oct 19;4:149-55. doi: 10.2147/JEP.S35396. PMID: 27186127; PMCID: PMC4863553.	View
DSIP-Sleep-Inducing	National Library of Medicine (NIH)	Stroke, Ischemic Brain Injury	Effects of delta-sleep-inducing peptide during ischemic injury of the rat brain	Shandra AA, Godlevskiĭ LS, Brusentsov AI, Vast’ianov RS, Karliuga VA, Dzygal AF, Nickel B. Effekty del’ta-son-indutsiruiushchego peptida v usloviiakh ishemicheskogo povrezhdeniia golovnogo mozga u krys [Effects of delta-sleep-inducing peptide during ischemic injury of the rat brain]. Ross Fiziol Zh Im I M Sechenova. 1997 Mar;83(3):95-9. Russian. PMID: 12436688.	View
DSIP-Sleep-Inducing	National Library of Medicine (NIH)	Insomnia	Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study	Bes F, Hofman W, Schuur J, Van Boxtel C. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology. 1992;26(4):193-7. doi: 10.1159/000118919. PMID: 1299794.	View
DSIP-Sleep-Inducing	National Library of Medicine (NIH)	Epilepsy	The effects of delta sleep-inducing peptide on incidence and severity in metaphit-induced epilepsy in rats	Stanojlović OP, Zivanović DP, Susić VT. The effects of delta sleep-inducing peptide on incidence and severity in metaphit-induced epilepsy in rats. Pharmacol Res. 2002 Mar;45(3):241-7. doi: 10.1006/phrs.2001.0938. PMID: 11884222.	View
DSIP-Sleep-Inducing	National Library of Medicine (NIH)	Alcohol, Opiate Withdrawal	DSIP in the treatment of withdrawal syndromes from alcohol and opiates	Dick P, Costa C, Fayolle K, Grandjean ME, Khoshbeen A, Tissot R. DSIP in the treatment of withdrawal syndromes from alcohol and opiates. Eur Neurol. 1984;23(5):364-71. doi: 10.1159/000115715. PMID: 6548969.	View
BPC-157	National Library of Medicine (NIH)	Hormone Regulation	Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts	Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014 Nov 19;19(11):19066-77. doi: 10.3390/molecules191119066. PMID: 25415472; PMCID: PMC6271067.	View
BPC-157	National Library of Medicine (NIH)	Anti-Inflammtory	Antiinflammatory effect of BPC 157 on experimental periodontitis in rats	Keremi B, Lohinai Z, Komora P, Duhaj S, Borsi K, Jobbagy-Ovari G, Kallo K, Szekely AD, Fazekas A, Dobo-Nagy C, Sikiric P, Varga G. Antiinflammatory effect of BPC 157 on experimental periodontitis in rats. J Physiol Pharmacol. 2009 Dec;60 Suppl 7:115-22. PMID: 20388954.	View
BPC-157	National Library of Medicine (NIH)	Brain-Gut (GI – Gastrointestinal)	Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications	Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, Grgic T, Strbe S, Zukanovic G, Crvenkovic D, Madzarac G, Rukavina I, Sucic M, Baric M, Starcevic N, Krstonijevic Z, Bencic ML, Filipcic I, Rokotov DS, Vlainic J. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865. doi: 10.2174/1570159×13666160502153022. PMID: 27138887; PMCID: PMC5333585.	View
BPC-157	National Library of Medicine (NIH)	Central Nervous System (Brain-Gut Axis)	Pentadecapeptide BPC 157 and the central nervous system	Vukojevic J, Milavić M, Perović D, Ilić S, Čilić AZ, Đuran N, Štrbe S, Zoričić Z, Filipčić I, Brečić P, Seiverth S, Sikirić P. Pentadecapeptide BPC 157 and the central nervous system. Neural Regen Res. 2022 Mar;17(3):482-487. doi: 10.4103/1673-5374.320969. PMID: 34380875; PMCID: PMC8504390.	View
GHK-Cu	National Library of Medicine (NIH)	Skin Regeneration (Tissue Repair)	GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration	Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. doi: 10.1155/2015/648108. Epub 2015 Jul 7. PMID: 26236730; PMCID: PMC4508379.	View
GHK-Cu	National Library of Medicine (NIH)	Anti-Aging	The potential of GHK as an anti-aging peptide	Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020 Mar 27;2(1):58-61. doi: 10.31491/apt.2020.03.014. PMID: 35083444; PMCID: PMC8789089.	View
GHK-Cu	National Library of Medicine (NIH)	Hair Growth	The effect of tripeptide-copper complex on human hair growth in vitro	Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007 Jul;30(7):834-9. doi: 10.1007/BF02978833. PMID: 17703734.	View
CJC-1295-ND	National Library of Medicine (NIH)	Growth Hormone	An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma	Timms M, Ganio K, Forbes G, Bailey S, Steel R. An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma. Drug Test Anal. 2019 Jun;11(6):804-812. doi: 10.1002/dta.2554. Epub 2018 Dec 25. PMID: 30489688.	View
CJC-1295-ND	National Library of Medicine (NIH)	Enhanced Muscle, Fat Loss, Improved Sleep	Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions	Van Hout MC, Hearne E. Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Subst Use Misuse. 2016 Jan 2;51(1):73-84. doi: 10.3109/10826084.2015.1082595. Epub 2016 Jan 15. PMID: 26771670.	View
Epithalon	National Library of Medicine (NIH)	Gene Expression (DNA Regulation)	AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism	Khavinson V, Diomede F, Mironova E, Linkova N, Trofimova S, Trubiani O, Caputi S, Sinjari B. AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules. 2020 Jan 30;25(3):609. doi: 10.3390/molecules25030609. PMID: 32019204; PMCID: PMC7037223.	View
Epithalon	National Library of Medicine (NIH)	Cardiovascular, Endocrine, Immune & Nervous Systems	Geroprotective effect of thymalin and epithalamin	Khavinson VKh, Morozov VG. Geroprotektornaia éffektivnost’ timalina i épitalamina [Geroprotective effect of thymalin and epithalamin]. Adv Gerontol. 2002;10:74-84. Russian. PMID: 12577695.	View
Ipamorelin	National Library of Medicine (NIH)	Bone Mineral Content (Bone Density)	The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats	Svensson J, Lall S, Dickson SL, Bengtsson BA, Rømer J, Ahnfelt-Rønne I, Ohlsson C, Jansson JO. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. J Endocrinol. 2000 Jun;165(3):569-77. doi: 10.1677/joe.0.1650569. PMID: 10828840.	View
Ipamorelin	National Library of Medicine (NIH)	Metabolism	Metabolism of growth hormone releasing peptides	Thomas A, Delahaut P, Krug O, Schänzer W, Thevis M. Metabolism of growth hormone releasing peptides. Anal Chem. 2012 Dec 4;84(23):10252-9. doi: 10.1021/ac302034w. Epub 2012 Nov 13. PMID: 23101768.	View
Melanotan-MT2	National Library of Medicine (NIH)	Melanin	Effect of MELANOTAN, [Nle(4), D-Phe(7)]-alpha-MSH, on melanin synthesis in humans with MC1R variant alleles	Fitzgerald LM, Fryer JL, Dwyer T, Humphrey SM. Effect of MELANOTAN, [Nle(4), D-Phe(7)]-alpha-MSH, on melanin synthesis in humans with MC1R variant alleles. Peptides. 2006 Feb;27(2):388-94. doi: 10.1016/j.peptides.2004.12.038. Epub 2005 Nov 15. PMID: 16293341.	View
Melanotan-MT2	National Library of Medicine (NIH)	Appetite and Body Mass	Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction	Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction	View
Melanotan-MT2	National Library of Medicine (NIH)	Addiction	Melatonin in drug addiction and addiction management: Exploring an evolving multidimensional relationship	Onaolapo OJ, Onaolapo AY. Melatonin in drug addiction and addiction management: Exploring an evolving multidimensional relationship. World J Psychiatry. 2018 Jun 28;8(2):64-74. doi: 10.5498/wjp.v8.i2.64. PMID: 29988891; PMCID: PMC6033744.	View
Melanotan-MT2	National Library of Medicine (NIH)	Erectile Dysfunction (ED)	Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II	Wessells H, Levine N, Hadley ME, Dorr R, Hruby V. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. Int J Impot Res. 2000 Oct;12 Suppl 4:S74-9. doi: 10.1038/sj.ijir.3900582. PMID: 11035391.	View
Melanotan-MT2	National Library of Medicine (NIH)	Binge Drinking (Addiction)	The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice	Olney JJ, Sprow GM, Navarro M, Thiele TE. The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice. Neuropeptides. 2014 Feb;48(1):47-51. doi: 10.1016/j.npep.2013.11.001. Epub 2013 Nov 15. PMID: 24290566; PMCID: PMC3946855.	View
Melanotan-MT2	National Library of Medicine (NIH)	Autism	Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder	Lalanne S, Fougerou-Leurent C, Anderson GM, Schroder CM, Nir T, Chokron S, Delorme R, Claustrat B, Bellissant E, Kermarrec S, Franco P, Denis L, Tordjman S. Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder. Int J Mol Sci. 2021 Feb 2;22(3):1490. doi: 10.3390/ijms22031490. PMID: 33540815; PMCID: PMC7867370.	View
Melanotan-MT2	National Library of Medicine (NIH)	Sexual Libido	Melatonin enhances sexual behavior in the male rat	Brotto LA, Gorzalka BB. Melatonin enhances sexual behavior in the male rat. Physiol Behav. 2000 Feb;68(4):483-6. doi: 10.1016/s0031-9384(99)00204-8. PMID: 10713287.	View
Melanotan-MT2	National Library of Medicine (NIH)	Childhood Autism	Melatonin and Comorbidities in Children with Autism Spectrum Disorder	Gagnon K, Godbout R. Melatonin and Comorbidities in Children with Autism Spectrum Disorder. Curr Dev Disord Rep. 2018;5(3):197-206. doi: 10.1007/s40474-018-0147-0. Epub 2018 Aug 9. PMID: 30148039; PMCID: PMC6096870.	View
Mots-C	National Library of Medicine (NIH)	Metabolic Stress	Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging	Wan W, Zhang L, Lin Y, Rao X, Wang X, Hua F, Ying J. Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. J Transl Med. 2023 Jan 20;21(1):36. doi: 10.1186/s12967-023-03885-2. PMID: 36670507; PMCID: PMC9854231.	View
Mots-C	National Library of Medicine (NIH)	Diabetes (Insulin Resistance)	Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases	Kong BS, Lee C, Cho YM. Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases. Diabetes Metab J. 2023 May;47(3):315-324. doi: 10.4093/dmj.2022.0333. Epub 2023 Feb 24. PMID: 36824008; PMCID: PMC10244198.	View
Mots-C	National Library of Medicine (NIH)	Osteoporis	MOTS-c improves osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via TGF-β/Smad pathway	Hu BT, Chen WZ. MOTS-c improves osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via TGF-β/Smad pathway. Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7156-7163. doi: 10.26355/eurrev_201811_16247. PMID: 30468456.	View
Mots-C	National Library of Medicine (NIH)	Mitochondrial Energy	MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation	Zheng Y, Wei Z, Wang T. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Front Endocrinol (Lausanne). 2023 Jan 25;14:1120533. doi: 10.3389/fendo.2023.1120533. PMID: 36761202; PMCID: PMC9905433.	View
Mots-C	National Library of Medicine (NIH)	Metabolic Disorders, Obesity (Weight Loss)	MOTS-c Functionally Prevents Metabolic Disorders	Gao Y, Wei X, Wei P, Lu H, Zhong L, Tan J, Liu H, Liu Z. MOTS-c Functionally Prevents Metabolic Disorders. Metabolites. 2023 Jan 13;13(1):125. doi: 10.3390/metabo13010125. PMID: 36677050; PMCID: PMC9866798.	View
Semaglutide	National Library of Medicine (NIH)	Appetite, Weight Loss	Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity	Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, Hjerpsted JB. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017 Sep;19(9):1242-1251. doi: 10.1111/dom.12932. Epub 2017 May 5. PMID: 28266779; PMCID: PMC5573908.	View
Semaglutide	National Library of Medicine (NIH)	Alzheimer’s Disease	Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer’s disease via the GLP-1R/SIRT1/GLUT4 pathway	Wang ZJ, Li XR, Chai SF, Li WR, Li S, Hou M, Li JL, Ye YC, Cai HY, Hölscher C, Wu MN. Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer’s disease via the GLP-1R/SIRT1/GLUT4 pathway. Neuropharmacology. 2023 Dec 1;240:109716. doi: 10.1016/j.neuropharm.2023.109716. Epub 2023 Sep 18. PMID: 37730113.	View
Semaglutide	National Library of Medicine (NIH)	Alzheimer’s Disease	Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism	Wang Y, Hu H, Liu X, Guo X. Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism. Front Pharmacol. 2023 Feb 23;14:1138499. doi: 10.3389/fphar.2023.1138499. PMID: 36909158; PMCID: PMC9995522.	View
Semaglutide	National Library of Medicine (NIH)	Insulin Secretion, Diabetes	Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial	Kapitza C, Dahl K, Jacobsen JB, Axelsen MB, Flint A. Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial. Diabetologia. 2017 Aug;60(8):1390-1399. doi: 10.1007/s00125-017-4289-0. Epub 2017 May 19. PMID: 28526920; PMCID: PMC5491562.	View
Tirzepatide	National Library of Medicine (NIH)	Diabetes	Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective	De Block C, Bailey C, Wysham C, Hemmingway A, Allen SE, Peleshok J. Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective. Diabetes Obes Metab. 2023 Jan;25(1):3-17. doi: 10.1111/dom.14831. Epub 2022 Aug 31. PMID: 35929488; PMCID: PMC10087310.	View
Tirzepatide	National Library of Medicine (NIH)	Weight Loss	Weight loss efficiency and safety of tirzepatide: A Systematic review	Lin F, Yu B, Ling B, Lv G, Shang H, Zhao X, Jie X, Chen J, Li Y. Weight loss efficiency and safety of tirzepatide: A Systematic review. PLoS One. 2023 May 4;18(5):e0285197. doi: 10.1371/journal.pone.0285197. PMID: 37141329; PMCID: PMC10159347.	View
Tirzepatide	National Library of Medicine (NIH)	Digestion	Tirzepatide as a novel effective and safe strategy for treating obesity: a systematic review and meta-analysis of randomized controlled trials	Cai W, Zhang R, Yao Y, Wu Q, Zhang J. Tirzepatide as a novel effective and safe strategy for treating obesity: a systematic review and meta-analysis of randomized controlled trials. Front Public Health. 2024 Jan 31;12:1277113. doi: 10.3389/fpubh.2024.1277113. PMID: 38356942; PMCID: PMC10864442.	View
Tirzepatide	National Library of Medicine (NIH)	Appetite (Weight Loss)	Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes	Heise T, DeVries JH, Urva S, Li J, Pratt EJ, Thomas MK, Mather KJ, Karanikas CA, Dunn J, Haupt A, Milicevic Z, Coskun T. Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes. Diabetes Care. 2023 May 1;46(5):998-1004. doi: 10.2337/dc22-1710. PMID: 36857477; PMCID: PMC10154650.	View
Tirzepatide	National Library of Medicine (NIH)	Diabetes, Insulin Senstivity, Obesity	Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review	Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review	View

Product Notice

Consumers are responsible for understanding the chemical safety, proper usage, and appropriate storage of this product.
This product is intended for research and educational purposes only and is not meant to diagnose, cure, treat, or prevent any disease or health condition.
This product has not been approved by the FDA for human or animal consumption and should not be used as a substitute or generic equivalent of any FDA-approved drug with similar chemical properties.

Storage and Handling Guidelines

Do NOT reconstitute until immediately before intended use. Reconstituted peptides are more vulnerable to degradation and contamination.
Store in powder form to maintain maximum stability and shelf life.
Keep lyophilized powder sealed in a cool, dry place—refrigerate (2–8°C) for short-term storage (up to 6 weeks) and freeze (–20°C or lower) for long-term storage (more than 6 weeks).
Avoid repeated freeze-thaw cycles.
Use sterile syringes and techniques when reconstituting to prevent contamination such as mold or bacterial growth.
Use only sterile, properly stored bacteriostatic water (BAC water) for reconstitution. Do not use BAC water that has been opened beyond 28 days or stored under improper conditions.
After reconstitution, store in a sterile vial and refrigerate. For best results, use within 4 to 6 weeks.

Important Notice

These are general storage and handling guidelines only.
Degradation can occur due to factors such as temperature changes, contamination, light exposure, and handling errors.
Proper storage and handling are the responsibility of the customer.
Product stability cannot be guaranteed beyond the stated recommendations.
Omega Peptides, LLC is not liable for any issues arising from improper use or storage.